IPP Bureau
IMCD and Friesland Campina Professional expand distribution agreement across EMEA
By IPP Bureau - July 11, 2025
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
Ichnos Glenmark Innovation announces global commercialization strategy for ISB 2001
By IPP Bureau - July 11, 2025
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Shilpa Medicare Unit VI facility at Dabaspet receives GMP certification from SFDA
By IPP Bureau - July 11, 2025
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Azelis acquires Azienda Chimica e Farmaceutica to expand presence in Italy
By IPP Bureau - July 11, 2025
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Bayer submits EU application for Gadoquatrane MRI contrast agent
By IPP Bureau - July 11, 2025
It is intended for contrast enhancement in MRI scans
Apollo AyurVAID launches India’s first ‘Tested Safe’ ayurveda products
By IPP Bureau - July 11, 2025
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
GlaxoSmithKline Pharmaceuticals appoints Vishwanath Swarup as Commercial Head - General Medicines
By IPP Bureau - July 11, 2025
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Syngene announces 3rd year of STEM scholarship for women with RICH
By IPP Bureau - July 11, 2025
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
EU launches strategies to strengthen crisis readiness and health security
By IPP Bureau - July 11, 2025
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Bayer receives first approval for Lynkuet in UK as treatment for vasomotor symptoms associated with menopause
By IPP Bureau - July 11, 2025
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
FDA approves Bravecto Quantum from Merck Animal Health
By IPP Bureau - July 11, 2025
FDA accepts new drug application for Merck’s Doravirine/Islatravir
By IPP Bureau - July 11, 2025
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Pfizer and Astellas' Xtandi combo extends survival in early prostate cancer setting
By IPP Bureau - July 11, 2025
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
Takara Bio Europe inks distribution agreement with Macherey-Nagel
By IPP Bureau - July 11, 2025
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Merck to acquire Verona Pharma for US$ 10 billion
By IPP Bureau - July 10, 2025
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
